Lab Design Tool的动态

Medical Affairs before 2030: the strategic capabilities you need today https://lnkd.in/expe5HhA Join us at Reuters Pharma 2024 in Barcelona for an insightful panel discussion on Tuesday April 16 at 17:20. Gary Lyons, our Chief Transformation Officer, will share valuable perspectives on: - Underpinning engagement strategies with data and analytics - Accelerating evidence generation - Investing in AI for increased efficiencies - Creating custom-built engagement tools for Medical Science Liaisons (MSLs). This session is a must-attend for professionals seeking to drive patient outcomes and stay ahead in the evolving biopharmaceutical landscape. We look forward to seeing you there. https://lnkd.in/expe5HhA #REPharma2024 #MedicalCommunications #HEOR #MarketAccess #WeAreAvalereHealth

Biopharma dealmaking is a key contributor to overall R&D productivity—but the competition among biopharmaceutical companies for externally sourced assets is heating up. In this new article, my McKinsey colleagues outline four practices that can help companies identify and secure external assets to help beat industry odds: ?? Harness artificial intelligence/machine learning to identify and assess external innovation early ?? Streamline decision-making processes in both dealmaking and asset integration ?? Collaborate with the external innovation ecosystem to maximize the value of your partnerships ?? Build deep expertise with a laser focus on a therapeutic area (TA) or pathway biology The end goal? Refine external innovation strategies, operations, and capabilities to ensure investments deliver much-needed healthcare innovations. Learn more here: https://lnkd.in/ezXR5MFD Check out McKinsey’s eight-ingredient recipe for R&D success in life sciences here: https://lnkd.in/eWVRj-sD

Innovations in technology are transforming the landscape of clinical trials and drug discovery by speeding up data analysis, increasing accuracy, and opening up new avenues for groundbreaking treatments. Explore and learn how the combined efforts of HCLTech, Denodo, and AWS are equipping pharmaceutical companies, biotech organizations, and healthcare providers to gather detailed data insights from clinical research, facilitating faster and better-informed decisions: https://okt.to/0C3PRK #SuperchargingProgress #HCLTech

I'm excited to be joining biopharma industry leaders, clients and colleagues this week for the JP Morgan Healthcare Conference in SF! This year, we are thrilled to share a newly launched collection of articles, “RewiR&D: Making more medicines that matter,” which contains actionable strategies for pharmaceutical companies aiming to improve R&D productivity and adapt to an evolving landscape. In this new collection of insights, my colleagues and I explain why disruptive innovation, urgent action, and systematic execution - including technology modernization - will be key to improving outcomes in the year ahead. The end goal? Help life sciences organizations deliver life-changing medicines to patients faster. Check out the “RewiR&D: Making more medicines that matter” collection here: https://lnkd.in/eScEEcbx

Checkout how technology is revamping clinical trials and drug discovery by accelerating data analysis, enhancing precision and unlocking new possibilities for innovative treatments. Learn how HCLTech, Denodo & AWS integrated solution is empowering pharmaceutical companies, biotech firms and healthcare organizations to capture comprehensive data insights from clinical studies, enabling quicker and more informed decision-making: https://okt.to/xaB4yu

Year-End Sale – Unleash the Power of Data-Driven Insights! Our Annual Year-End Sale is live, and we’re offering up to 30% off on our entire portfolio of Healthcare and Life Sciences Reports! Why should this matter to you? - Access the latest trends and growth forecasts to 2034, giving you the foresight to stay ahead in a fast-evolving market. - Dive deep into competitive insights and discover where your company stands. - Explore 60+ geographies to capitalize on growth opportunities globally. Whether you’re driving advancements in healthcare systems, biopharmaceutical innovations, or cutting-edge medical devices, these reports are your key to making smarter, strategic decisions. They offer clear, actionable insights to help you stay ahead of your competition and unlock future growth. Time’s running out—this offer is limited! Take advantage of this opportunity before it’s gone. Explore our collection of healthcare reports and stay one step ahead. Act now to secure your advantage! https://lnkd.in/g4KGZMHK . . . #lifesciences #healthcareresearch #datadrivendecisions #innovationinhealth #marketgrowth #competitiveadvantage #yearendsale #thelifescienceresearchcompany

The realm of clinical trials and drug development is undergoing a significant change due to advancements in technology that enhance data analysis speed, increase precision, and create new opportunities for innovative treatments. Learn about how the partnership among HCLTech, Denodo, and AWS is empowering pharmaceutical firms, biotech companies, and healthcare organizations to extract valuable insights from clinical research, enabling quicker and more informed decision-making: https://okt.to/NXWBim

What are you most excited to learn about at this year's Disruptive Technology for Clinical Trials Summit? Ahead of his session in Boston, MA, USA on 8 October, we were thrilled to speak with Alex Sverdlov, Senior Director, Statistical Scientist, Novartis to find out what he’s looking forward to most at this year’s edition. From current digital technologies and platforms trends, decentralized clinical trials, and emerging regulatory perspectives, Alex is looking forward to uniting with industry leaders from top pharma organizations to debate and discuss top strategies to Accelerate Clinical R&D, Connectivity, and Patient-Centric Outcomes. Be a part of the discussion and save 25% by registering with 4THJULY2025 today*: https://lnkd.in/eMg3JacE *Offer ends 10 July 2024. Exclusions apply.?Cannot be combined with other offers. Email [email protected] for more info. #Disruptivetechnology #ClinicalTrials #StatisticalScience #DrugDevelopment #Innovation #AMGWorld #DisruptiveClinicalTrials

A lot of folks have been asking me about what MasterControl does, and so many people in my background are in the Pharma, Life Sciences Manufacturing / CDMO and Biomedical industries and this one is for you! Take a listen in and understand how MasterControl can help you with the #1 MES SaaS offering!

??Canyon Labs ?????????????? ???????????????????????? ???????? ?????????????????? ?????????????????????? ???? iuvo BioScience'?? ?????? ?????????????????? Canyon Labs, a global leader in analytical & packaging lab testing for medical devices and pharmaceuticals, has acquired iuvo BioScience’s laboratory services and scientific consulting divisions. This strategic acquisition enhances Canyon Labs’ ability to offer end-to-end solutions in pharmaceutical and medical device development, while enabling iuvo BioScience to sharpen its focus on ophthalmic clinical research. The integration of iuvo's lab and consulting teams into Canyon Labs expands capabilities, including advanced sterility, biocompatibility testing, microbiology, and analytical chemistry. Canyon Labs, with support from MedVenture Health, operates across Salt Lake City, San Diego, and Rochester, NY, reinforcing its position as a leader in outsourced testing and consulting services. This move strengthens Canyon Labs’ commitment to raising industry standards and advancing medical product safety. #MergersAndAcquisitions #MedicalDevices #Pharmaceuticals #Ophthalmology #HealthcareInnovation #CRO